Kinaset Therapeutics
Kinaset Therapeutics develops novel respiratory drugs to address unmet medical needs.
Founded
2020Kinaset Therapeutics develops novel respiratory drugs to address unmet medical needs.
Kinaset Therapeutics, founded with a mission to address unmet medical needs in respiratory health, focuses on developing innovative inhaled therapeutics for respiratory diseases. The company aims to create novel drugs that can significantly improve the quality of life for individuals suffering from intractable respiratory conditions. Their product pipeline is centered around advanced respiratory treatments designed to offer new hope where existing therapies fall short.
Notable figures affiliated with Kinaset Therapeutics include experienced professionals from the pharmaceutical and biotech industries, contributing their expertise to drive the company's mission forward. The company has attracted investment from leading venture capital firms, underscoring confidence in its potential impact. Key achievements include the development of promising drug candidates that have shown efficacy in preclinical studies, positioning Kinaset Therapeutics as a significant player in the respiratory therapeutics market.
Companies similar to Kinaset Therapeutics include Metera Pharmaceuticals, Respira Therapeutics, Axikin Pharmaceuticals and KinDex Pharmaceuticals.
Kinaset Therapeutics was founded in 2020.
Kinaset Therapeutics' headquarters is located in Medfield, MA, US.
Kinaset Therapeutics' most recent funding round was for $40M (USD) in November 2020.
As of Nov 30, 2020, Kinaset Therapeutics has disclosed funding of $41.5M (USD). Undisclosed round amounts are excluded.
Kinaset Therapeutics has 11 employees as of Feb 5, 2024.
KinDex Pharmaceuticals
